Mark Genovese

31PUBLICATIONS
60CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursOther education not elsewhere classifiedClinical pharmacology and therapeuticsSensory systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jun 11, 2026
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity.

|Jan 30, 2025
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study.

Rene Westhovens, Kevin L Winthrop, Arthur Kavanaugh

|Oct 30, 2023
Reply.

Matthew C Baker, Mark C Genovese, Konstantinos Alataris

|Oct 12, 2023
Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives.

Yoshiya Tanaka, Mark C Genovese, Hironori Matsushima

|Jun 30, 2023
A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis.

Matthew C Baker, Sarah Kavanagh, Stanley Cohen

|Nov 06, 2021
Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years.

Kevin L Winthrop, Yoshiya Tanaka, Tsutomu Takeuchi

Pageof 6

Frequent Collaborators

4 joint publications

Gerd R Burmester

4 joint publications

Rieke Alten

3 joint publications

Kevin L Winthrop

2 joint publications

Robin Besuyen